Finished
Role of Virtual Reality in MS Rehabilitation
NCT02834533 · IRCCS Centro Neurolesi Bonino Pulejo · Updated 18 July 2016
- What is being tested
- Lokomat
- For
- Multiple Sclerosis Relapse
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 30 years to 65 years. About 40 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started Jan 2014, ends Jan 2015. Registered 15 July 2016.
- Results
- None posted yet.
In the researchers' words
Objective: To investigate the role of virtual reality (VR) paired with robotic-assisted gait training (RAGT) compared with RAGT alone in patients with Multiple Sclerosis (MS). Method: A Randomized, double-blind, controlled clinical trial was carried out in forty patients with relapsing remitting MS. All patients were randomized into two groups. One group practiced Lokomat without VR (group G1), the other one the Lokomat with VR (G2). Both the groups performed 40-1h-training sessions by Lokomat (for 3 times a week). A skilled-blinded neurologist and psychologist administered clinical and neuropsychological scales. All the clinical tests were performed at the beginning (T0) and at the end (T1) of the rehabilitative program.